文献速递头颈外科咽喉与嗓音

窄带成像在早期声门癌经口激光手术中的随机对照试验

Narrow-Band Imaging in Transoral Laser Surgery for Early Glottic Cancer: A Randomized Controlled Trial.
PubMed 文献 · Otolaryngol Head Neck Surg · 2023-02-23

在荷兰一家三级转诊医院开展的随机对照试验(2015年9月至2022年11月)纳入113例早期喉癌患者,比较经口激光手术单纯使用白光成像(WLI,n=56)与联合窄带成像(NBI,n=57)的临床结局。NBI组切缘阳性数显著少于WLI组(16 vs 31,p=.002);18个月时NBI组无复发生存率更高(96% vs 84%,p=.02)、复发率更低(2/57 vs 9/56,p=.02),但12个月及研究终止时差异未达统计学显著。

要点

  • NBI辅助经口激光手术显著减少早期声门癌切缘阳性(16 vs 31,p=.002)。
  • 18个月时NBI组无复发生存率96% vs WLI组84%(p=.02),复发率2/57 vs 9/56(p=.02)。
  • 12个月及研究终止时无复发生存率与复发率差异未达统计学显著。

核心结论

  • 经口激光手术中额外使用NBI显著减少切缘阳性数;尽管并非所有时间点均达统计学显著,NBI支持组复发率更低、无复发生存率更好,需在更大患者群中进一步研究证实。

研究设计与样本

  • 随机对照试验,2015年9月至2022年11月在荷兰一家三级转诊医院开展,共113例患者接受经口激光手术,单纯白光成像组56例,联合窄带成像组57例,术后定期喉镜随访。

主要发现

  • 白光成像组31例切缘阳性 vs 窄带成像组16例(p=.002)。
  • 12个月无复发生存率总体92%:白光成像组87% vs 窄带成像组96%(p=.07);复发率白光成像组7/56(13%) vs 窄带成像组2/57(4%)(p=.09)。
  • 18个月无复发生存率白光成像组84% vs 窄带成像组96%(p=.02);复发率白光成像组9/56(16%) vs 窄带成像组2/57(4%)(p=.02)。
  • 研究终止时(最长86个月)无复发生存率白光成像组71% vs 窄带成像组83%(p=.08);复发率白光成像组16/56 vs 窄带成像组10/57(p=.16)。

临床怎么用

  • 作者认为,经口激光手术治疗早期喉癌时额外使用窄带成像可减少切缘阳性,并可能降低复发、改善无复发生存,但需更大样本研究证实。

局限性

  • 原文指出需在更大患者群中进一步研究以证实这些结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Assessing whether the additional use of narrow-band imaging (NBI) in transoral laser surgery (TOLS) for early laryngeal cancer improves clinical outcomes. STUDY DESIGN: Randomized controlled trial, performed between September 2015 and November 2022. SETTING: A tertiary referral hospital in The Netherlands. METHODS: TOLS was carried out in 113 patients. The procedure was performed with white light imaging (WLI, n = 56) alone, or combined with NBI (n = 57). Patients received frequent follow-up laryngoscopy. Resection margin status, recurrence rate, and recurrence-free survival at 12 months, 18 months, and after study termination (maximum 86 months) were analyzed. RESULTS: Thirty-one cases in the WLI group had a positive resection margin, versus 16 in the NBI group (p = .002). After 12 months, the recurrence-free survival was 92%: 87% for WLI versus 96% for NBI, p = .07. The recurrence rate was 7/56 (13%) for WLI, versus 2/57 (4%) for NBI, p = .09. After 18 months, the recurrence-free survival was 84% for WLI versus 96% for NBI, p = .02. The recurrence rate was 9/56 (16%) for WLI, versus 2/57 (4%) for NBI, p = .02. After study termination, the recurrence-free survival was 71% for WLI versus 83% for the NBI group (p = .08). The recurrence rate was 16/56 for WLI, versus 10/57 for NBI (p = .16). CONCLUSION: The additional use of NBI during TOLS significantly decreased the number of positive resection margins. Although not statistically significant at all time points, patients treated with NBI-supported TOLS showed a lower recurrence rate and better recurrence-free survival. Further studies in larger patient groups are needed to confirm these results.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Zwakenberg MA, Westra JM, Halmos GB, et al. Narrow-Band Imaging in Transoral Laser Surgery for Early Glottic Cancer: A Randomized Controlled Trial. Otolaryngol Head Neck Surg. 2023. PMID: 36821814. doi:10.1002/ohn.307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。